Regulation & law · 15/09/2022Updated: 10/17/2026 · 1 min read
Ajinomoto Bio-Pharma Services to Establish Pharmaceutical Production Facility in Foreign-Trade Zone 153-San Diego
Summary
Ajinomoto Bio-Pharma Services has submitted a notification to the US government to establish a pharmaceutical production facility in Foreign-Trade Zone 153-San Diego, California, as part of its proposed production activity.
Original source language: Federal Register — All DocumentsOpen original release →